corydine has been researched along with isocorydine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, MM; Kirby, GC; Marshall, SJ; Phillipson, JD; Russell, PF; Schiff, PL; Warhurst, DC; Wright, CW | 1 |
| Borges, S; Chan, TM; Fischmann, T; Gullo, VP; Hegde, VR; Kirschmeier, P; Madison, V; Patel, M; Pu, H; Williams, MJ; Wu, B | 1 |
| Di, D; Han, Y; Li, R; Li, W; Liu, J; Xin, A; Yan, Q; Zhang, Y | 1 |
3 other study(ies) available for corydine and isocorydine
| Article | Year |
|---|---|
In vitro antiplasmodial, antiamoebic, and cytotoxic activities of some monomeric isoquinoline alkaloids.
Topics: Alkaloids; Amebicides; Animals; Antimalarials; Entamoeba histolytica; Isoquinolines; Plasmodium falciparum; Structure-Activity Relationship | 2000 |
Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.
Topics: Aristolochic Acids; CDC2 Protein Kinase; Cell Line, Tumor; Computer Simulation; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Pyrazoles; Quinolines; Structure-Activity Relationship | 2010 |
Design, synthesis, and anticancer properties of isocorydine derivatives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aporphines; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship | 2017 |